Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients

por Christopher J. Mowry, MD, Cristina Alonso, PhD, Marta Iruarrizaga-Lejarreta, PhD, Pablo Ortiz, MD, PhD, Josh Levitsky, MD, MS, Mary Rinella, MD
Publicado 2021